C Products Defense, Inc. – Trademark Portfolio

Entity Type: 03

C Products Defense, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 13 (Firearms) — 18 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 3 are pending. Notable registered marks include CPD, D360, T-360, DURAMAG, and LIPLOCK. The owner is based in Bradenton, FL.

6115 31 Street East

Bradenton, FL 34203

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

C Products Defense, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

13
Firearms (18 filings)

Firearms; ammunition and projectiles; explosives; fireworks

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does C Products Defense, Inc. have?

C Products Defense, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 12 registered, 3 pending, 2 abandoned, 2 cancelled.

What trademark classes does C Products Defense, Inc. file in?

C Products Defense, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 13 (Firearms), Class 40 (Treatment & Processing). Class 13 covers firearms; ammunition and projectiles; explosives; fireworks.

What are C Products Defense, Inc.'s most well-known trademarks?

C Products Defense, Inc.'s registered trademark portfolio includes well-known marks such as CPD, D360, T-360, DURAMAG, and LIPLOCK. These are among 12 currently registered trademarks in the portfolio.

What is C Products Defense, Inc.'s trademark registration success rate?

C Products Defense, Inc. has a 75% trademark registration rate, with 12 out of 16 resolved applications resulting in successful registration. Currently, 3 applications are pending review.